| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by (used in) financing activities | 47,305 | -79 |
| Net change in cash, cash equivalents, and restricted cash | 11,216 | -24,987 |
| Cash and cash equivalents at beginning of period | 65,663 | - |
| Cash and cash equivalents at end of period | 76,879 | - |
Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corp (CAMP)